Search research publications and outputs

  1. 2014
  2. 2013
  3. JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells

    Kroon, P., Berry, P. A., Stower, M. J., Rodrigues, G., Mann, V. M., Simms, M., Bhasin, D., Chettiar, S., Li, C., Li, P-K., Maitland, N. J. & Collins, A. T., 3 Jul 2013

    Article in Cancer research

  4. A preclinical xenograft model of prostate cancer using human tumors

    Lawrence, M. G., Taylor, R. A., Toivanen, R., Pedersen, J., Norden, S., Pook, D. W., Frydenberg, M., Papargiris, M. M., Niranjan, B., Richards, M. G., Wang, H., Collins, A. T., Maitland, N. J., Risbridger, G. P. & Australian Prostate Cancer BioResource, 4 Apr 2013

    Article in Nature Protocols

  5. Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells

    Polson, E. S., Lewis, J. L., Celik, H., Mann, V. M., Stower, M. J., Simms, M. S., Rodrigues, G., Collins, A. T. & Maitland, N. J., 27 Mar 2013

    Article in Nature Communications

  6. 2012
  7. Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status (vol 30, pg 1087, 2012)

    Taylor, R. A., Toivanen, R., Frydenberg, M., Pedersen, J., Harewood, L., Collins, A. T., Maitland, N. J., Risbridger, G. P. & Australian Prostate, Aug 2012

    Article in Stem Cells

  8. Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status

    Taylor, R. A., Toivanen, R., Frydenberg, M., Pedersen, J., Harewood, L., Australian Prostate Cancer Bioresource, N. V., Collins, A. T., Maitland, N. J. & Risbridger, G. P., Jun 2012

    Article in Stem cells (Dayton, Ohio)

  9. In Vitro Primary Cell Culture as a Physiologically Relevant Method for Preclinical Testing of Human Oncolytic Adenovirus

    Adamson, R. E., Frazier, A. A., Evans, H., Chambers, K. F., Schenk, E., Essand, M., Birnie, R., Mitry, R. R., Dhawan, A. & Maitland, N. J., 1 Feb 2012

    Article in HUMAN GENE THERAPY

  10. A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer

    Magnusson, M. K., Kraaij, R., Leadley, R. M., De Ridder, C. M. A., van Weerden, W. M., Van Schie, K. A. J., Van der Kroeg, M., Hoeben, R. C., Maitland, N. J. & Lindholm, L., 1 Jan 2012

    Article in HUMAN GENE THERAPY

  11. 2011
  12. Baculoviruses as gene therapy vectors for human prostate cancer

    Rivera-Gonzalez, G. C., Swift, S. L., Dussupt, V., Georgopoulos, L. J. & Maitland, N. J., Jul 2011

    Article in Journal of invertebrate pathology

  13. Use of macrophages to target therapeutic adenovirus to human prostate tumors

    Muthana, M., Giannoudis, A., Scott, S. D., Fang, H-Y., Coffelt, S. B., Morrow, F. J., Murdoch, C., Burton, J., Cross, N., Burke, B., Mistry, R., Hamdy, F., Brown, N. J., Georgopoulos, L., Hoskin, P., Essand, M., Lewis, C. E. & Maitland, N. J., 1 Mar 2011

    Article in Cancer research

  14. 2010
  15. Gene Transfer Vectors Targeted to Human Prostate Cancer: Do We Need Better Preclinical Testing Systems?

    Maitland, N., Chambers, K., Georgopoulos, L., Simpson-Holley, M., Leadley, R., Evans, H., Essand, M., Danielsson, A., van Weerden, W., de Ridder, C., Kraaij, R., Bangma, C. H. & GIANT FP6 Consortium, Jul 2010

    Article in HUMAN GENE THERAPY

  16. Phenotypic effects of HPV-16 E2 protein expression in human keratinocytes

    Burns, J. E., Walker, H. F., Schmitz, C. & Maitland, N. J., Jun 2010

    Article in VIROLOGY

  17. Engineering Macrophages to Synthesize Recombinant Adenoviruses in Hypoxic Areas of Human Prostate Tumours

    Muthana, M., Giannoudis, A., Scott, S. D., Mistry, R., Murdoch, C., Georgeopolous, L., Hamdy, F., Brown, N., Maitland, N. & Lewis, C. E., Apr 2010

    Article in HUMAN GENE THERAPY

  18. 2009
  19. Human prostate stem cells support replication of a prostate-targeted, conditionally replicating adenovirus

    Frazier, A., Carlisle, R., Evans, H., Georgopoulos, L., Thomson, A., Fisher, K., Seymour, L. & Maitland, N., Nov 2009

    Article in HUMAN GENE THERAPY

  20. Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood

    Georgopoulos, L. J., Elgue, G., Sanchez, J., Dussupt, V., Magotti, P., Lambris, J. D., Tötterman, T. H., Maitland, N. J. & Nilsson, B., Sep 2009

    Article in Molecular immunology

  21. 2008
  22. 2007
  23. A role for the heparin-binding cytokines pleiotrophin and midkine in prostate cancer?

    Rumsby, M., Simmonds, J., Sharrard, M., Bland, M., Rodrigues, G., Stower, M. & Maitland, N., Sep 2007

    Article in BJU International

  24. 2006
  25. Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context

    Chapel-Fernandes, S., Jordier, F., Lauro, F., Maitland, N., Chiaroni, J., de Micco, P., Mannoni, P. & Bagnis, C., Oct 2006

    Article in Cancer gene therapy

  26. Gene therapy for prostate cancer: Current strategies and new cell-based approaches

    MacRae, E. J., Giannoudis, A., Ryan, R., Brown, N. J., Hamdy, F. C., Maitland, N. & Lewis, C. E., 1 Apr 2006

    Literature review in Prostate

  27. 2005
  28. Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues

    Riddick, A. C. P., Shukla, C. J., Pennington, C. J., Bass, R., Nuttall, R. K., Hogan, A., Sethia, K. K., Ellis, V., Collins, A. T., Maitland, N. J., Ball, R. Y. & Edwards, D. R., 20 Jun 2005

    Article in British journal of cancer

  29. 2004
  30. CD133, a novel marker for human prostatic epithelial stem cells

    Richardson, G. D., Robson, C. N., Maitland, N., Lang, S. H., Neal, D. E. & Collins, A. T., 15 Jul 2004

    Article in Journal of Cell Science

  31. Optimization of a synthetic beta-catenin-dependent promoter for tumor-specific cancer gene therapy

    Lipinski, K. S., Djeha, H. A., Gawn, J., Cliffe, S., Maitland, N. J., Palmer, D. H., Mountain, A., Irvine, A. S. & Wrighton, C. J., Jul 2004

    Article in Molecular therapy

  32. Human papillomaviruses and cancer in Uganda

    Newton, R., Bousarghin, L., Ziegler, J., Casabonne, D., Beral, V., Mbidde, E., Carpenter, L., Parkin, D. M., Wabinga, H., Mbulaiteye, S., Jaffe, H., Touzé, A., Coursaget, P., Sembajwe, V., Kalinaki, M., Byansi, R., Rwatooro, C., Nambooze, S., Tushimiere, B., Byabazaire, N. & 10 others, Bitamazire, E., Katabira, E., Mugerwa, J., Tindyebura, D., Ateenyi-Agaba, C., Whitworth, J., Richardson, B., Reeves, G., Weiss, R. & De Cock, K., Apr 2004

    Article in European journal of cancer prevention

  33. Targeting gene therapy for prostate cancer

    Maitland, N. J., Stanbridge, L. J. & Dussupt, V., 2004

    Literature review in Current pharmaceutical design

  34. 2003
  35. 2002
  36. Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma

    Lang, S. H., Hyde, C., Reid, I. N., Hitchcock, I. S., Hart, C. A., Bryden, A. A. G., Villette, J-M., Stower, M. J. & Maitland, N. J., 1 Sep 2002

    Article in Prostate

  37. Recombinant adenovirus vector activates and protects human monocyte-derived dendritic cells from apoptosis

    Lundqvist, A., Choudhury, A., Nagata, T., Andersson, T., Quinn, G., Fong, T., Maitland, N., Pettersson, S., Paulie, S. & Pisa, P., Sep 2002

    Article in HUMAN GENE THERAPY

  38. Mutations of the BRAF gene in human cancer

    Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, N., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A. & 32 others, Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W. C., Leung, S. Y., Yuen, S. T., Weber, B. L., Siegler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R. & Futreal, P. A., 27 Jun 2002

    Article in Nature

  39. The structure of S100A12 in a hexameric form and its proposed role in receptor signalling

    Moroz, O. V., Antson, A. A., Dodson, E. J., Burrell, H. J., Grist, S. J., Lloyd, R. M., Maitland, N. J., Dodson, G. G., Wilson, K. S., Lukanidin, E. & Bronstein, I. B., Mar 2002

    Article in Acta Crystallographica Section D: Biological Crystallography

  40. 2001
  41. In vitro modelling of the prostate: 3D culture of prostatic cells in matrigel

    Lang, S. H., Stark, M., Hall, J., Hyde, K., Stower, M. & Maitland, N. J., Jul 2001

    Article in British journal of cancer

Previous 1 2 Next